Dana Davis Selected Research

Agammaglobulinaemia Tyrosine Kinase

1/2015

Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dana Davis Research Topics

Disease

3	Neoplasms (Cancer) 01/2019 - 01/2017
2	Fibrosis (Cirrhosis) 01/2022 - 01/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 10/2018
1	Idiopathic Pulmonary Fibrosis 11/2019
1	Asbestosis 01/2019
1	Pneumonia (Pneumonitis) 11/2018
1	Disease Progression 10/2018
1	Body Weight (Weight, Body) 11/2015
1	Rheumatoid Arthritis 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012

Drug/Important Bio-Agent (IBA)

1	venetoclaxIBA 01/2022
1	mitochondrial calcium uniporterIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	CytokinesIBA 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	AsbestosIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	SmokeIBA 11/2018
1	IpilimumabIBA 10/2018
1	Immune Checkpoint InhibitorsIBA 10/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2018
1	Triglycerides (Triacylglycerol)IBA 11/2015
1	SugarsIBA 11/2015
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	RN486IBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2012
1	Immunotherapy 10/2018